Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-12

Clinical Trial Update: Assessment of Three-dimensional Vision Alteration in Parkinson Disease [NA]

View source ↗

Summary

A completed clinical trial evaluated three-dimensional vision alterations in individuals with Parkinson disease (NCT01620164) conducted at University Hospital, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease | NA | Status: COMPLETED